Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy-Reference-Cited by-同舟云学术

Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy

Published:2012-12 Issue:12 Volume:111 Page:705-710
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Tsai Tzung-Jiun,Lai Kwok-Hung,Hsu Ping-I.,Lin Chiun-Ku,Chan Hoi-Hung,Yu Hsien-Chung,Wang Huay-Min,Lin Kung-Hung,Wang Kai-Ming,Chang Shiuh-Nan,Liu Chun-Peng,Hsiao Shin-Hung,Huang Hung-Ru,Lin Ching-Huang,Tsay Feng-Woei

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration;BMJ,1994

2. Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans;Feldman;Am J Physiol Gastrointest Liver Physiol,2000

3. Endoscopy in asymptomatic minidose aspirin consumers;Niv;Dig Dis Sci,2005

4. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin;Yeomans;Aliment Pharmacol Ther,2005

5. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials;McQuaid;Am J Med,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term use of low-dose aspirin and the risk of Helicobacter pylori infection and the effect of Helicobacter pylori eradication treatment: A Prospective Case-Control Analysis;2024-05-09

2. Mide prekanseröz lezyonlarında klopidogrel kullanımının değerlendirilmesi: Kemopreventif etkisi var mı?;Journal of Medicine and Palliative Care;2023-10-27

3. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view;World Journal of Cardiology;2023-08-26

4. Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy;Diagnostics;2022-09-29

5. Risk of Post-Myocardial Infarction Pneumonia with Proton Pump Inhibitors, H2 Receptor Antagonists and Mucoprotective Agents: A Retrospective Nationwide Cohort Study;Journal of Personalized Medicine;2022-01-09